ZYBT
Zhengye Biotechnology Holding Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.37
+0.00%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.41
From 52W high−85.53%
Volume19227.00
Market cap$40.72M
P/E (TTM)—
P/S (TTM)2.3x
Div yield—
Key dataSep 18, 2026
Open
$1.41
From 52W high
−85.53%
Volume
19227.00
Market cap
$40.72M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−8.3x
P/E (TTM)
—
RSI (14)
42.7
MomentumView details →
1D Return
+0.00%
YTD Return
+20.00%
SummaryUpdated Dec 1, 2025
Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) is a Chinese veterinary vaccine manufacturer that went public in January 2025. Founded in 2004 and headquartered in Jilin, China, the company has established itself as a specialized producer of vaccines for livestock and companion animals. Operating as a subsidiary of Securingium Holding Limited, Zhengye has built its business around serving China's large agricultural sector while also expanding into international markets including Vietnam, Pakistan, and Egypt.
Similar companies
Latest newsMore news →